Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: Results of a pilot study

Clinical Research in Cardiology

Volumn 100, Issue 8, 2011, Pages 683-690

  Baumann, Gert ^a   Stangl, Verena ^a   Klein Weigel, Peter ^b   Stangl, Karl ^a   Laule, Michael ^a   Enke Melzer, Kathrin ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b German Red Cross Hospital   (Germany)

^c HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

Author keywords

Buerger's disease; Immunoadsorption; Thromboangiitis obliterans

Indexed keywords

GLOBULIN; PROSTANOID;

ADOLESCENT; ADULT; ANGIOGRAPHY; ARTICLE; BUERGER DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE COURSE; DOPPLER FLOWMETRY; FEMALE; FOLLOW UP; GANGRENE; HEART PERFUSION; HUMAN; IMMUNOADSORPTION; MALE; MICROCIRCULATION; OXYGEN TENSION; PAIN; PHOTOELECTRIC PLETHYSMOGRAPHY; PILOT STUDY; RATING SCALE; TISSUE OXYGENATION; TREADMILL; TREATMENT OUTCOME; ULCER; ULTRASOUND; WALKING; WOUND HEALING;

ADULT; ANGIOGRAPHY; ANTIBODIES, ANTI-IDIOTYPIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PILOT PROJECTS; THROMBOANGIITIS OBLITERANS; TREATMENT OUTCOME;

EID: 80051801500     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0298-z     Document Type: Article

References (35)

1. JW Olin 2000 Thromboangiitis obliterans (Buerger's disease) N Engl J Med 343 864 869 10995867 10.1056/NEJM200009213431207 1:STN:280: DC%2BD3cvjvFenug%3D%3D
2. JL Mills JM Porter 1991 Buerger's disease (thromboangiitis obliterans) Ann Vasc Surg 5 570 572 1772769 10.1007/BF02015288 1:STN:280: DyaK387is1CrsA%3D%3D
3. JL Mills 2003 Buerger's disease in the 21st century: diagnosis, clinical features, and therapy Semin Vasc Surg 16 179 189 12975757 10.1016/S0895-7967(03) 00023-1 (Pubitemid 37129829)
4. GA McLoughlin CR Helsby CC Evans DM Chapman 1976 Association of HLA-A9 and HLA-B5 with Buerger's disease Br Med J 2 1165 1166 990826 10.1136/bmj.2.6045.1165 1:STN:280:DyaE2s%2Fks1Ciuw%3D%3D
5. P de Moerloose M Jeannet P Mirimanoff CA Bouvier 1979 Evidence for an HLA-linked resistance gene in Buerger's disease Tissue Antigens 14 169 173 91227 10.1111/j.1399-0039.1979.tb00835.x (Pubitemid 9256951)
6. J Eichhorn D Sima C Lindschau, et al. 1998 Antiendothelial cell antibodies in thromboangiitis obliterans Am J Med Sci 315 17 23 9427570 10.1097/00000441-199801000-00004 1:STN:280:DyaK1c%2FoslCnsA%3D%3D (Pubitemid 28047565)
7. KS Halacheva IM Manolova DP Petkov AP Andreev 1998 Study of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger's disease) Scand J Immunol 48 544 550 9822265 1:STN:280:DyaK1M%2FjvVSmuw%3D%3D (Pubitemid 28505681)
8. M Kobayashi M Ito A Nakagawa N Nishikimi Y Nimura 1999 Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease J Vasc Surg 29 451 458 10069909 10.1016/S0741-5214(99)70273-9 1:STN:280:DyaK1M7mvFamsA%3D%3D (Pubitemid 29152267)
9. M Kobayashi N Nishikimi K Komori 2006 Current pathological and clinical aspects of Buerger's disease in Japan Ann Vasc Surg 20 148 156 16378138 10.1007/s10016-005-9436-2 (Pubitemid 43029874)
10. SM Gulati K Madhra TK Thusoo SK Nair K Saha 1982 Autoantibodies in thromboangiitis obliterans (Buerger's Disease) Angiology 33 642 651 6751163 10.1177/000331978203301003 1:STN:280:DyaL3s%2FitVGqtQ%3D%3D (Pubitemid 12004935)
11. AY Hershko Y Naparstek 2005 Removal of pathogenic autoantibodies by immunoadsorption Ann N Y Acad Sci 1051 635 646 16127004 10.1196/annals.1361.108 1:CAS:528:DC%2BD2MXhtFaktLfL (Pubitemid 41362791)
12. F Moreso R Poveda S Gil-Vernet, et al. 1995 Therapeutic immunoadsorption in Goodpasture disease Med Clin 105 59 61 1:STN:280:DyaK2Mzis1KrtQ%3D%3D
13. L Psaridi-Linardaki N Trakas A Mamalaki SJ Tzartos 2005 Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen specific therapeutic strategy J Neuroimmunol 159 183 191 15652418 10.1016/j.jneuroim.2004.10.002 1:CAS:528:DC%2BD2MXisl2qtw%3D%3D (Pubitemid 40126191)
14. GH Stummvoll M Aringer JS Smolen, et al. 2005 IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: A long term observational study Ann Rheum Dis 64 1015 1021 15640267 10.1136/ard.2004.029660 1:CAS:528:DC%2BD2MXntFGltbc%3D (Pubitemid 40909515)
15. A Palmer D Taube K Welsh M Bewick P Gjorstrup M Thick 1989 Removal of anti HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation Lancet 1 10 12 2563001 10.1016/S0140-6736(89)91672-3 1:STN:280:DyaL1M%2Fps1Srug%3D%3D (Pubitemid 19035213)
16. WV Dörffel SB Felix G Wallukat, et al. 1997 Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy Circulation 95 1994 1997 9133505 (Pubitemid 27184263)
17. SB Felix A Staudt WV Dörffel, et al. 2000 Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study J Am Coll Cardiol 35 1590 1598 10807465 10.1016/S0735-1097(00)00568-4 1:STN:280: DC%2BD3c3msFOntw%3D%3D (Pubitemid 30307505)
18. A Staudt F Schäper V Stangl, et al. 2001 Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution Circulation 103 2681 2682 11390337 1:CAS:528:DC%2BD3MXltFCjtbg%3D
19. A Staudt A Hummel J Ruppert, et al. 2006 Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study Am Heart J 152 e1 e6 16996843 10.1016/j.ahj.2006.06.027 (Pubitemid 44396901)
20. II Müller K Klingel VO Nikolaev R Jahns MP Gawaz HJ Weig 2008 Immunoadsorption in a 40 year old man with dilated cardiomyopathy and underlying active myocarditis Clin Res Cardiol 97 787 790 18633566 10.1007/s00392-008- 0689-y
21. D Bulut M Scheeler T Wichmann J Börgel T Miebach A Mügge 2010 Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy Clin Res Cardiol 99 633 638 20419455 10.1007/s00392-010-0162-6 1:CAS:528:DC%2BC3cXhtF2ksr3P
22. E Minar 2009 Critical limb ischaemia Hämostasiologie 29 102 109 1:STN:280:DC%2BD1M7kslOmsg%3D%3D
23. JT Farrar YL Pritchett M Robinson A Prakash A Chappell 2010 The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders J Pain 11 109 118 19665938 10.1016/j.jpain.2009.06.007 1:CAS:528:DC%2BC3cXhs1GrtbY%3D
24. M Cachovan W Rogatti F Woltering, et al. 1999 Randomized reliability study evaluating constant-load and graded-exercise treadmill test for intermittent claudication Angiology 50 193 200 10088798 10.1177/ 000331979905000303 1:STN:280:DyaK1M7os1Kmuw%3D%3D (Pubitemid 29138425)
25. KI Paraskevas 2008 Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue Clin Rheumatol 27 547 18246380 10.1007/s10067-008-0843-y
26. H Tavakoli J Salimi A Rashidi 2008 Reply: "Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue" Clin Rheumatol 27 813 18404238 10.1007/s10067-008-0883-3
27. JN Fiessinger M Schäfer 1990 Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study Lancet 335 555 557 1689791 10.1016/0140-6736(90)90346-7 1:STN:280:DyaK3c7ntlGqtA%3D%3D (Pubitemid 20089238)
28. JM Isner I Baumgartner G Rauh, et al. 1998 Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results J Vasc Surg 28 964 973 9845647 10.1016/S0741-5214(98)70022-9 1:STN:280:DyaK1M%2FmtFyktQ%3D%3D
29. K Miyamoto K Nishigami N Nagaya, et al. 2006 Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans Circulation 114 2679 2684 17145986 10.1161/CIRCULATIONAHA.106.644203 (Pubitemid 44967352)
30. Y Saito K Sasaki Y Katsuda, et al. 2007 Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease Circ J 71 1187 1192 17652879 10.1253/circj.71.1187 (Pubitemid 47195332)
31. Z Boda M Udvardy K Rázsó, et al. 2009 Stem cell therapy: A promising and prospective approach in the treatment of patients with severe Buerger's disease Clin Appl Thromb Hemost 15 552 560 18818231 10.1177/1076029608319882
32. + cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blind, dose-escalation clinical trial Stem Cells 27 2857 2864 19711453 10.1002/stem.207 1:CAS:528: DC%2BC3cXlsFyrsw%3D%3D
33. RK Burt A Testori Y Oyama, et al. 2010 Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia Bone Marrow Transplant 45 111 116 19448678 10.1038/bmt.2009.102 1:STN:280: DC%2BC3c%2FhvFCrsw%3D%3D
34. R Rivera 1973 Roentgenographic diagnosis of Buerger's disease J Cardiovasc Surg 14 40 46 1:STN:280:DyaE3s7jsFOrtg%3D%3D
35. X Puéchal JN Fiessinger 2007 Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist Rheumatology 46 192 199 17116654 10.1093/rheumatology/kel388 (Pubitemid 46189775)